iCAD to Present at UBS Global Life Sciences Conference
NASHUA, N.H., Sept. 19 / -- iCAD, Inc., an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced that Ken Ferry, Chief Executive Officer, and Darlene Deptula-Hicks, Executive Vice President and Chief Financial Officer of iCAD, will present a corporate update at the UBS Global Life Sciences Conference on Wednesday, September 26th at 1:00 p.m. (Eastern Daylight Time) at the Grand Hyatt New York.
The presentation will be webcast live and archived for replay on the "Investors" section of the company's Web site at http://www.icadmed.com/.
About iCAD, Inc.
iCAD, Inc. is an industry-leading provider of Computer- Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by over one thousand women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit http://www.icadmed.com/.
For iCAD, contact Darlene Deptula-Hicks, EVP and CFO at 603-882-5200 x7944 or via email at ddeptula@icadmed.com
For iCAD Public Relations, contact Wendy Ryan of Schwartz Communications at 781-684-0770 or via email at icad@schwartz-pr.com
FCMN Contact: kambrogio@schwartz-pr.com
Source: iCAD, Inc.
CONTACT:Darlene Deptula-Hicks, EVP and CFO of iCAD, +1-603-882-5200, x7944, ddeptula@icadmed.com
Web site: http://www.icadmed.com/
